MARS Study Replacing Hepatic Function In Severe Acute Liver Failure

The Molecular Adsorbent Recirculating System (MARS) is FDA-approved for toxin ingestion, refractory hepatic encephalopathy and chronic liver disease.  A study accepted by the Annals of Surgery of 27 patients finds that in using MARS, physicians are able to get trauma patients with massive liver injury to recovery and, in patients who are deemed good transplant candidates, get them to transplant with excellent survivals. Read the journal article here.

Related Presenters

Steven Hanish, MD.

Steven Hanish, MD

Dr. Steven Hanish is an Associate Professor of Surgery at the University of Maryland School of Medicine and director of hepatobiliary surgery at the University of Maryland Medical Center. He received his medical degree from the Indiana ...

View full profile

Deborah Stein, MD.

Deborah Stein, MD

Deborah M. Stein MD, MPH, earned her Bachelor of Arts degree from Cornell University, her Medical Degree from Albert Einstein College of Medicine and her Master of Public Health from Johns Hopkins University Bloomberg School of Public ...

View full profile